Evidence map›Paper›PMID 25751150›Full record

ArticlePloS one2015

Alcohol induced alterations to the human fecal VOC metabolome.

Robin D Couch, Allyson Dailey, Fatima Zaidi, Karl Navarro, Christopher B Forsyth, Ece Mutlu, Phillip A Engen, Ali Keshavarzian

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Robin D CouchDepartment of Chemistry and Biochemistry, George Mason University, Manassas, Virginia, United States of America.
Allyson DaileyDepartment of Chemistry and Biochemistry, George Mason University, Manassas, Virginia, United States of America.
Fatima ZaidiDepartment of Chemistry and Biochemistry, George Mason University, Manassas, Virginia, United States of America.
Karl NavarroDepartment of Chemistry and Biochemistry, George Mason University, Manassas, Virginia, United States of America.
Christopher B ForsythDepartment of Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, United States of America; Department of Biochemistry, Rush University Medical Center, Chicago, Illinois, United States of America.
Ece MutluDepartment of Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, United States of America.
Phillip A EngenDepartment of Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, United States of America.
Ali KeshavarzianDepartment of Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, United States of America; Department of Pharmacology, Rush University Medical Center, Chicago, Illinois, United States of America; Department of Molecular Biophysics and Physiology, Rush University Medical Center, Chicago, Illinois, United States of America; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
George Mason University · USRush University Medical Center · US

Funding

Systems Biology Approach to Identifying Biomarkers for Alcoholic Liver DiseaseRC2AA019405 · NIAAA · RUSH UNIVERSITY MEDICAL CENTER · PI GILLEVET, PATRICK MARTIN, KESHAVARZIAN, ALI · 2009 to 2010
$2.0M
NIAAA NIH HHS 1RC2AA019405NIAAA NIH HHS RC2 AA019405
6 · The paper itself

Abstract

Studies have shown that excessive alcohol consumption impacts the intestinal microbiota composition, causing disruption of homeostasis (dysbiosis). However, this observed change is not indicative of the dysbiotic intestinal microbiota function that could result in the production of injurious and toxic products. Thus, knowledge of the effects of alcohol on the intestinal microbiota function and their metabolites is warranted, in order to better understand the role of the intestinal microbiota in alcohol associated organ failure. Here, we report the results of a differential metabolomic analysis comparing volatile organic compounds (VOC) detected in the stool of alcoholics and non-alcoholic healthy controls. We performed the analysis with fecal samples collected after passage as well as with samples collected directly from the sigmoid lumen. Regardless of the approach to fecal collection, we found a stool VOC metabolomic signature in alcoholics that is different from healthy controls. The most notable metabolite alterations in the alcoholic samples include: (1) an elevation in the oxidative stress biomarker tetradecane; (2) a decrease in five fatty alcohols with anti-oxidant property; (3) a decrease in the short chain fatty acids propionate and isobutyrate, important in maintaining intestinal epithelial cell health and barrier integrity; (4) a decrease in alcohol consumption natural suppressant caryophyllene; (5) a decrease in natural product and hepatic steatosis attenuator camphene; and (6) decreased dimethyl disulfide and dimethyl trisulfide, microbial products of decomposition. Our results showed that intestinal microbiota function is altered in alcoholics which might promote alcohol associated pathologies.

Indexed as

AdultAlkanesBicyclic MonoterpenesCase-Control StudiesDisulfidesEthanolFatty Acids, VolatileFatty AlcoholsFecesFemaleHumansMaleMetabolomeMicrobiotaMiddle AgedPolycyclic SesquiterpenesAlkanesBicyclic Monoterpenescamphenecaryophyllenedimethyl disulfidedimethyl trisulfideDisulfidesEthanolFatty Acids, VolatileFatty Alcoholsn-tetradecanePolycyclic SesquiterpenesSesquiterpenesSulfidesTerpenesVolatile Organic Compounds

Identifiers

PMID25751150
PMCPMC4353727
OpenAlexW1978924764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.